The therapeutic efficacy of transcranial magnetic stimulation for major depressive disorder; A brain functional imaging study

The therapeutic efficacy of transcranial magnetic stimulation for major depressive disorder; A brain functional imaging study - The therapeutic efficacy of transcranial magnetic stimulation for major depression

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001157

Enrollment

Registered

2008-05-15

Start date

2008-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder

Interventions

We will stimulate left dorsolateral prefrontal cortex with high-frequency over 3 weeks. We will stimulate right dorsolateral prefrontal cortex with low-frequency over 3 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who meet with DSM-IV-TR criteria for major depressive disorder

Exclusion criteria

Exclusion criteria: Exculsion criteria includes severe medical illness, a history of convulsive disorder, and severe suicide idea.

Design outcomes

Primary

Measure	Time frame
We will evaluate regional cerebral blood flow associated with the therapeutic efficacy of transcranial magnetic stimulation.	—

Countries

Japan

Contacts

Public ContactShinsuke Kito

Kyorin University School of Medicine Department of Neuropsychiatry

psychiat@kyorin-u.ac.jp0422-47-5511

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026